These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 11462017)

  • 41. Rat T cell responses to superantigens. II. Allelic differences in V beta 8.2 and V beta 8.5 beta chains determine responsiveness to staphylococcal enterotoxin B and mouse mammary tumor virus-encoded products.
    Gold DP; Surh CD; Sellins KS; Schroder K; Sprent J; Wilson DB
    J Exp Med; 1994 Jan; 179(1):63-9. PubMed ID: 8270884
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Deletion of peripheral V beta 14+ T cells by Mtv-2-encoded viral superantigen preceded by blastogenesis and DNA synthesis but not by specific expansion.
    Nakano H; Yoshimoto T; Nariuchi H; Kakiuchi T; Matsuzawa A
    Cell Immunol; 1996 Mar; 168(2):281-90. PubMed ID: 8640876
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A mouse mammary tumor virus-like long terminal repeat superantigen in human breast cancer.
    Wang Y; Jiang JD; Xu D; Li Y; Qu C; Holland JF; Pogo BG
    Cancer Res; 2004 Jun; 64(12):4105-11. PubMed ID: 15205319
    [TBL] [Abstract][Full Text] [Related]  

  • 44. I-J revisited: is the I-J genetic restriction in downregulation due to an endogenous superantigen analogous to mammary tumour virus (Mtv)-encoded endogenous superantigen?
    Asherson GL; Dieli F; Tomonari K
    Folia Biol (Praha); 1994; 40(6):341-7. PubMed ID: 7589693
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Presentation of the Mls-1 superantigen by human HLA class II molecules to murine T cells.
    Subramanyam M; McLellan B; Labrecque N; Sekaly RP; Huber BT
    J Immunol; 1993 Sep; 151(5):2538-45. PubMed ID: 8395548
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mutational and functional analysis of the C-terminal region of the C3H mouse mammary tumor virus superantigen.
    Wrona TJ; Lozano M; Binhazim AA; Dudley JP
    J Virol; 1998 Jun; 72(6):4746-55. PubMed ID: 9573239
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Requirement of class II and membrane proximal region of mouse mammary tumor virus superantigen (Mtv SAG) in Mtv7 SAG presentation].
    Okamoto M; Kimura S; Katagiri M
    Hokkaido Igaku Zasshi; 1998 May; 73(3):205-14. PubMed ID: 9719947
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Superantigens and murine mammary tumor retrovirus].
    Piazzon I; Nepomnaschy I; Buggiano V; Bekinschtein P; Goldman A; Berguer P; Deroche A; Lombardi G
    Medicina (B Aires); 1997; 57 Suppl 2():21-33. PubMed ID: 9567341
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exogenous mouse mammary tumor virus (MMTV) infection induces endogenous MMTV sag expression.
    Xu L; Wrona TJ; Dudley JP
    Virology; 1996 Jan; 215(2):113-23. PubMed ID: 8560758
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transposon-mediated random insertions and site-directed mutagenesis prevent the trafficking of a mouse mammary tumor virus superantigen.
    McMahon CW; Traxler B; Grigg ME; Pullen AM
    Virology; 1998 Apr; 243(2):354-65. PubMed ID: 9568034
    [TBL] [Abstract][Full Text] [Related]  

  • 51. TCR reactivity in human nickel allergy indicates contacts with complementarity-determining region 3 but excludes superantigen-like recognition.
    Vollmer J; Weltzien HU; Moulon C
    J Immunol; 1999 Sep; 163(5):2723-31. PubMed ID: 10453014
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential reactivity of TCR Vbeta10 alleles to a mouse mammary tumor virus superantigen.
    Maillard I; Xenarios I; Diggelmann H; Orbea HA
    Eur J Immunol; 1998 Oct; 28(10):3075-85. PubMed ID: 9808176
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differences in the avidity of TCR interactions with a superantigenic ligand affect negative selection but do not allow positive selection.
    Chervonsky AV; Golovkina TV; Ross SR; Janeway CA
    J Immunol; 1995 Dec; 155(11):5115-23. PubMed ID: 7594520
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Physiologic expression of two superantigens in the BDF1 mouse.
    Gollob KJ; Palmer E
    J Immunol; 1991 Oct; 147(8):2447-54. PubMed ID: 1655891
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regions of mouse mammary tumor virus superantigen involved in interaction with the major histocompatibility complex class II I-A molecule.
    Wirth S; Vessaz A; Krummenacher C; Baribaud F; Acha-Orbea H; Diggelmann H
    J Virol; 2002 Nov; 76(21):11172-5. PubMed ID: 12368363
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diverse fine specificity and receptor repertoire of T cells reactive to the major VP1 epitope (VP1230-250) of Theiler's virus: V beta restriction correlates with T cell recognition of the c-terminal residue.
    Kim BS; Bahk YY; Kang HK; Yauch RL; Kang JA; Park MJ; Ponzio NM
    J Immunol; 1999 Jun; 162(12):7049-57. PubMed ID: 10358147
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The use of mammary tumor virus (Mtv)-negative and single-Mtv mice to evaluate the effects of endogenous viral superantigens on the T cell repertoire.
    Scherer MT; Ignatowicz L; Pullen A; Kappler J; Marrack P
    J Exp Med; 1995 Nov; 182(5):1493-504. PubMed ID: 7595219
    [TBL] [Abstract][Full Text] [Related]  

  • 58. T cell receptor V alpha 4 is expressed by a subpopulation of V beta 6 T cells that respond to the bacterial superantigen staphylococcal enterotoxin B.
    Borrero H; Donson D; Cervera C; Rexer C; Macphail S
    J Immunol; 1995 May; 154(9):4247-60. PubMed ID: 7722285
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Non-exclusive Fas control and age dependence of viral superantigen-induced clonal deletion in lupus-prone mice.
    Papiernik M; Pontoux C; Golstein P
    Eur J Immunol; 1995 Jun; 25(6):1517-23. PubMed ID: 7542196
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Control of the rat T cell response to retroviral and bacterial superantigens by class II MHC products and Tcrb-V8.2 alleles.
    Herrmann T; Hochgrebe T; Torres-Nagel NE; Huber BT; Hünig T
    J Immunol; 1994 May; 152(9):4300-9. PubMed ID: 8157953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.